Drawing for VIABLYS

USPTO serial 99340217

VIABLYS

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
Examiner
STAHL, NICHOLE MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIABLYS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anthony E. Bennett

Anthony E. Bennett Hoffmann & Baron, LLP6900 Jericho TurnpikeSyosset, NY 11791United States

Goods and services

ClassDescriptionStatusFirst use
005Transdermal and adhesive skin patches for treating, alleviating or preventing the development or progression of food allergies, namely, peanut allergies in children; patches or epicutaneous systems comprised of medicated patches including a food allergen cutaneously or epicutaneously administered for treating, alleviating or preventing the development or progression of food allergies, namely, peanut allergies in children; adhesive patches or adhesive epicutaneous systems comprised of medicated patches including a food allergen cutaneously or epicutaneously administered for treating, alleviating or preventing the development or progression of food allergies, namely, peanut allergies in children; occlusive patches or occlusive epicutaneous systems comprised of medicated patches including a powdered food allergen cutaneously or epicutaneously administered for treating, alleviating or preventing the development or progression of food allergies, namely, peanut allergies in children; patches or epicutaneous systems comprised of medicated patches containing a powdered food allergen preparation for medical or pharmaceutical use for treating food allergies, namely, peanut allergies in children; patches or epicutaneous systems comprised of medicated patches including a food allergen, for use in the treatment of food allergies, namely, peanut allergies in children; patches or epicutaneous systems comprised of medicated patches including allergens for treating food allergies, namely, peanut allergies in children; pharmaceutical preparations for treating food allergies, namely, peanut allergies in children; parts and fittings for the aforesaid goodsACTIVE
010Non-medicated skin patches sold without medication for medical training purposes; non-medicated skin patches sold without medication, for medical use, namely for use in training medical professionals on the transdermal delivery of pharmaceuticals or medical preparations; parts and fittings for all the aforesaid goodsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2026ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Aug 21, 2026OTHECASE RETURNED TO EXAMINATION
Aug 21, 2026IUCNNOTICE OF ALLOWANCE CANCELLED
Aug 19, 2026JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 19, 2026PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Aug 19, 2026PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Aug 18, 2026APETASSIGNED TO PETITION STAFF
Jul 7, 2026TPADTEAS PETITION TO AMEND BASIS RECEIVED
May 12, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 17, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2026DOCKASSIGNED TO EXAMINER
Dec 31, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Aug 15, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance